The American Cancer Society will launch two national roundtables—one focused on cervical cancer, the other breast cancer—to bring together leading organizations and experts with the goal of improving health equity and access to cancer screening.
FDA has added stereotactic breast biopsy needles to its Medical Device Shortages List with an estimated duration of “through Q4 2026,” which spans July 1 to Sept. 30.
